[Virtual Conference] Inaugural Summit on GLP-1 Law & Policy

Or call 1-888-224-2480 for fastest service.

You can save 10% off* the current registration fee by using code D10-999-JDS25

The $100B+ Weight-Loss Drug Market Is Red Hot—But So Are the Legal, Regulatory, and Compliance Risks.

As the GLP-1 revolution reshapes the future of metabolic health, life sciences companies face mounting scrutiny from regulators, IP challenges from competitors, and exposure to litigation risks.

ACI’s Inaugural Summit on GLP-1 Law & Policy is the first legal and regulatory forum built specifically for those navigating the high-stakes obesity drug landscape. This virtual summit brings together top legal, compliance, and business minds to tackle the real-world challenges impacting the commercialization and risk management of GLP-1s and other emerging therapies.

Conference Co-Chairs:

The esteemed faculty of in-house and outside counsel in this emerging field will discuss:

• The market trends, legal risks, and regulatory shifts shaping weight-loss drugs from the IRA to FDA oversight
• The rising threat of biosimilar competition and IP actions against compounders
• Commercial concerns and market access from cost containment to long term market impact
• A look ahead at the future of the GLP-1 dug industry

Save 10% off* the current registration fee by using code D10-999-JDS25

*Discount is valid for new registrations only and it’s not applicable for workshops.